Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,601 to 1,620 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mass cytometric and transcriptomic profiling of epithelial-mesenchymal transitions in human mammary cell lines. | Sci Data | 2022 | 35140234 | PubTator, text mining | PubMed |
| Glioma targeted therapy: insight into future of molecular approaches. | Mol Cancer | 2022 | 35135556 | PubTator, text mining | PubMed |
| Noncoding RNAs from tissue-derived small extracellular vesicles: Roles in diabetes and diabetic complications. | Mol Metab | 2022 | 35121168 | PubTator, text mining | PubMed |
| L-fucose, a sugary regulator of antitumor immunity and immunotherapies. | Mol Carcinog | 2022 | 35107186 | PubTator, text mining | PubMed |
| A model of preferential pairing between epithelial and dendritic cells in thymic antigen transfer. | Elife | 2022 | 35099391 | PubTator, text mining | PubMed |
| Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection. | Trends Mol Med | 2022 | 35093288 | PubTator, text mining | PubMed |
| Inherited immunodeficiencies associated with proximal and distal defects in T cell receptor signaling and co-signaling. | Biomed J | 2022 | 35091087 | PubTator, text mining | PubMed |
| A CD8+ T Cell-Related Genes Expression Signature Predicts Prognosis and the Efficacy of Immunotherapy in Breast Cancer. | J Mammary Gland Biol Neoplasia | 2022 | 35088220 | PubTator, text mining | PubMed |
| Chimeric antigen receptor engineered T cells and their application in the immunotherapy of solid tumours. | Expert Rev Mol Med | 2022 | 35086597 | PubTator, text mining | PubMed |
| Fc-based Duokines: dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc). | Oncoimmunology | 2022 | 35083097 | PubTator, text mining | PubMed |
| Monoclonal Antibodies in Acute Myeloid Leukemia-Are We There Yet? | Cancer J | 2022 | 35072372 | PubTator, text mining | PubMed |
| How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia. | Cancer J | 2022 | 35072368 | PubTator, text mining | PubMed |
| Secreted phosphoprotein 1 as a potential prognostic and immunotherapy biomarker in multiple human cancers. | Bioengineered | 2022 | 35067176 | PubTator, text mining | PubMed |
| Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults. | Int J Epidemiol | 2022 | 35064782 | PubTator, text mining | PubMed |
| CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells. | Stem Cell Reports | 2022 | 35063129 | PubTator, text mining | PubMed |
| Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. | Mol Cancer | 2022 | 35062949 | PubTator, text mining | PubMed |
| Antitumor Peptide-Based Vaccine in the Limelight. | Vaccines (Basel) | 2022 | 35062731 | PubTator, text mining | PubMed |
| An atlas of dynamic peripheral blood mononuclear cell landscapes in human perioperative anaesthesia/surgery. | Clin Transl Med | 2022 | 35061932 | PubTator, text mining | PubMed |
| The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity. | Cancers (Basel) | 2022 | 35053463 | PubTator, text mining | PubMed |
| Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on "Off-the-Shelf" T Cell Therapy Using iPSC Technology and Gene Editing. | Cells | 2022 | 35053386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=81